Glenn R. Mattes, President and CEO at TFF Pharmaceuticals, Inc. (TFFP), bought 16,000 shares at $4.78 ($76K) on 2022-05-16, disclosed to the SEC on 2022-05-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TFFP | SELL | 2021-02-18 | $673K | — | Filing → |
| TFFP | SELL | 2021-01-20 | $1.5M | — | Filing → |
| TFFP | SELL | 2020-12-29 | $460K | — | Filing → |